Sodium Restriction in the Management of Cirrhotic Ascites
NCT00548366 · Status: TERMINATED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 68
Last updated 2010-09-14
Summary
To determine the relationship between degree of sodium restriction and dietary compliance with clinical outcome of diuresis of portal hypertensive ascites in cirrhotic patients from a county hospital population.
Primary objective: Demonstrate that, when accompanied by the appropriate diuretic regimen, a No Added Salt diet (4 grams sodium per day) is as effective as a Low Sodium diet (2 grams sodium per day) in the management of cirrhotic ascites.
Conditions
- Ascites
Interventions
- OTHER
-
Sodium restriction
4 gram sodium diet
- OTHER
-
Sodium restriction
2 gram sodium diet
Sponsors & Collaborators
-
University of Texas Southwestern Medical Center
lead OTHER
Principal Investigators
-
Jennifer A Cuthbert, M.D. · UT Southwestern Medical Center at Dallas
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- SINGLE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 18 Years
- Max Age
- 75 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2007-10-31
- Primary Completion
- 2009-12-31
- Completion
- 2010-09-30
Countries
- United States
Study Locations
More Related Trials
-
Comparison of Crystalloid and Colloid I.V Fluid Therapy in Prevention of Paracentesis Induced Circulatory Dysfunction (PICD) and Renal Dysfunction in Patients With Decompensated Liver Cirrhosis in Egypt: a Randomized Piolet Study
NCT05220891 ·Status: UNKNOWN
-
Tolvaptan for Hyponatremia in Cirrhotic Patients With Ascites
NCT01716611 ·Status: UNKNOWN ·Phase: PHASE4
-
Acute Hemodynamics of Albumin Versus Normal Saline in Cirrhosis
NCT00511394 ·Status: SUSPENDED ·Phase: NA
-
Terlipressin in Cirrhotic Patients With Recidivation Ascites Treated With Paracentesis and Albumin
NCT00986817 ·Status: COMPLETED ·Phase: PHASE3
-
Effect of Large Volume Paracentesis on Fatigue in Cirrhosis
NCT00603200 ·Status: WITHDRAWN
-
Recombinant Human Serum Albumin in Patients With Liver Cirrhosis and Ascites Subjects
NCT05249374 ·Status: COMPLETED ·Phase: PHASE1
-
The Influence of Paracentesis on Intra-abdominal Pressure and Kidney Function in Critically Ill Patients With Liver Cirrhosis and Ascites: an Observational Study
NCT01091233 ·Status: WITHDRAWN
-
Compare the Diuretic Effect With Furosemide vs Furosemide and Albumin Combined in Cirrhotic Patients
NCT04216784 ·Status: TERMINATED ·Phase: PHASE4
-
PEriToneal Catheter Versus Repeated Paracentesis for Ascites in Cirrhosis
NCT03027635 ·Status: TERMINATED ·Phase: NA
-
North American Study for the Treatment of Refractory Ascites (NASTRA)
NCT00006166 ·Status: COMPLETED ·Phase: PHASE3
-
Alfapump System Versus Transjugular Intrahepatic Portosystemic Shunt and Paracentesis in the Treatment of Ascites
NCT02612519 ·Status: TERMINATED ·Phase: NA
-
Satavaptan Dose-Ranging Study in Normonatraemic Patients With Cirrhotic Ascites
NCT00501566 ·Status: COMPLETED ·Phase: PHASE2
-
Low-dose Albumin Infusion for the Prevention of Paracentesis Induced Circulatory Dysfunction (PICD), After Large Volume Paracentesis (LVP) in Decompensated Cirrhosis Liver.
NCT06892535 ·Status: COMPLETED ·Phase: PHASE4
-
Effect of Samsca on Control of Hyponatremia and Extracellular Fluid in Cirrhotic Patients With Ascites
NCT01552590 ·Status: TERMINATED ·Phase: PHASE4
-
Vasoconstrictors as Alternatives to Albumin After Large-Volume Paracentesis (LVP) in Cirrhosis
NCT00108355 ·Status: COMPLETED ·Phase: PHASE4
-
Sodium-glucose Linked Transporter 2 (SGLT-2) Inhibitors in Recurrent Ascites: a Pilot RCT
NCT05014594 ·Status: UNKNOWN ·Phase: PHASE2
-
Empagliflozin as a Novel Therapy in Refractory Ascites
NCT05430243 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Effects of Maintaining Steady Albumin Levels (TAT 4) on Survival and Liver Related Complications in Cirrhosis With Ascites
NCT04058613 ·Status: UNKNOWN ·Phase: NA
-
Body Composition Analysis in Cirrhotic Undergoing Paracentesis
NCT02022150 ·Status: UNKNOWN
-
Mechanism and the Effect of Midodrine on Portal Pressures in Patients With Cirrhosis
NCT01331785 ·Status: WITHDRAWN ·Phase: NA
-
Initial Resuscitation for Acute Kidney Injury in Cirrhosis
NCT06525623 ·Status: RECRUITING ·Phase: NA
-
Phase II/III Clinical Trial of Recombinant Human Serum Albumin in Cirrhotic Patients With Ascites
NCT06553456 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Fresh Frozen Plasma as a Substitute for Albumin in Patients Receiving a Large Volume Paracentesis
NCT04109144 ·Status: WITHDRAWN ·Phase: PHASE2
-
Human Albumin for the Treatment of Ascites in Patients With Hepatic Cirrhosis
NCT01288794 ·Status: COMPLETED ·Phase: PHASE4
-
Satavaptan for the Prevention of Ascites Recurrence in Patients With Ascites Due to Cirrhosis of the Liver
NCT00366795 ·Status: TERMINATED ·Phase: PHASE3